Wuxi repurchases shares

- Last updated on GMT

Wuxi repurchases shares
China-based CRO Wuxi PharmaTech has repurchased shares from private equity fund General Atlantic LLC.

According to a statement issued earlier this week Wuxi will buy “all ordinary shares General Atlantic received on February 12, 2012, following the conversion in full of the $35m principal amount of convertible notes plus accrued interest of approximately $864,000​.”

Wuxi investor relations director Ron Aldridge told Outsourcing-pharma.com that move is intended "to accelerate EPS growth by reducing our share count​.” The deal is expected to close on February 24.

General Atlantic, which along with associated investment entities has held around 46m Wuxi shares – roughly a 9 per cent stake in the company – since 2007​, already lists the Chinese contract research organization (CRO) as a prior holding on its website.

The repurchase follows a few weeks after media speculation that Wuxi’s health profit margins - relative to its western peers – make it a potential takeover target.

At the time Oppenheimer analyst Ingrid Yin told Bloomberg that: “We see a big gap between WuXi and ShangPharma valuations versus their US peers, WuXi and ShangPharma are both very interesting potential targets. They represent a big opportunity in China​.”

Aldridge declined to comment on the takeover speculation.

Wuxi will announce its fourth quarter earnings on March 8.

Related topics: Clinical Development, Phase III-IV

Related news

Show more

Related products

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers